Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus
BackgroundGastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide treatm...
Main Authors: | Sejeong Park, So Young Park, Yu Jin Kim, Soo Min Hong, Suk Chon, Seungjoon Oh, Jeong-taek Woo, Sung-Woon Kim, Young Seol Kim, Sang Youl Rhee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2016-04-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-240.pdf |
Similar Items
-
Solid Nanocrystals of Rebamipide Promote Recovery from Indomethacin-Induced Gastrointestinal Bleeding
by: Noriaki Nagai, et al.
Published: (2019-10-01) -
The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen
by: Joonhwan Kim, et al.
Published: (2018-04-01) -
Rebamipide using in gastroesophageal reflux disease treatment
by: V. T. Ivashkin, et al.
Published: (2020-04-01) -
CLINICAL AND PHARMACOLOGICAL CHARACTERISTICS OF THE USE OF REBAMIPIDE IN DISEASES OF THE GASTROINTESTINAL TRACT LITERATURE REVIEW
by: V. I. SIMANENKOV, et al.
Published: (2016-12-01) -
Efficacy and Safety of Rebamipide in Prevention of NSAID-Gastropathy
by: Serhiy Tkach, et al.
Published: (2017-03-01)